Reviva Pharmaceuticals Holdings, Inc. - Common Stock (RVPH)
0.6791
+0.00 (0.00%)
NASDAQ · Last Trade: Oct 9th, 7:41 AM EDT
Detailed Quote
Previous Close
0.6791
Open
-
Bid
0.6918
Ask
0.7000
Day's Range
N/A - N/A
52 Week Range
0.2522 - 4.280
Volume
247,108
Market Cap
15.38M
PE Ratio (TTM)
-1.997
EPS (TTM)
-0.3
Dividend & Yield
N/A (N/A)
1 Month Average Volume
14,704,556
Chart
About Reviva Pharmaceuticals Holdings, Inc. - Common Stock (RVPH)
Reviva Pharmaceuticals Holdings Inc. is a biopharmaceutical company focused on developing innovative therapeutic solutions for conditions with significant unmet medical needs. The company primarily concentrates on advancing its proprietary drug candidates through clinical trials to address psychiatric, neurological, and inflammatory disorders. Reviva utilizes its expertise in pharmacology to create novel treatment options that aim to improve the lives of patients by targeting specific mechanisms of disease while minimizing side effects associated with traditional therapies. Through its research and development efforts, Reviva seeks to make meaningful contributions to the field of medicine and enhance patient outcomes. Read More
Looking for insights into the US markets one hour before the close of the markets on Wednesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
